EVOFEM BIOSCIENCES, INC. Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs
EVOFEM BIOSCIENCES, INC. (EVFM) reported Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs of $2.30 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-11.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts · last filed 2026-08-14
- EVOFEM BIOSCIENCES, INC. adjustments to additional paid in capital, stock issued, issuance costs for the quarter ending 2025-06-30 was $2.30M.
- EVOFEM BIOSCIENCES, INC. adjustments to additional paid in capital, stock issued, issuance costs for the quarter ending 2023-09-30 was $4.90M, a 19516.00% increase year-over-year.
- EVOFEM BIOSCIENCES, INC. adjustments to additional paid in capital, stock issued, issuance costs for the quarter ending 2022-09-30 was $25.00K.
- EVOFEM BIOSCIENCES, INC. adjustments to additional paid in capital, stock issued, issuance costs for the quarter ending 2019-09-30 was $60.00K.
- EVOFEM BIOSCIENCES, INC. adjustments to additional paid in capital, stock issued, issuance costs for fiscal 2025 was $2.30M.
- EVOFEM BIOSCIENCES, INC. adjustments to additional paid in capital, stock issued, issuance costs for fiscal 2019 was $60.00K.
| Period end | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs 3 month | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs 12 month |
|---|---|---|
| 2025-12-31 | $2.30M 10-K · filed 2026-03-11 | |
| 2025-06-30 | $2.30M 10-Q · filed 2026-08-14 | |
| 2023-09-30 | $4.90M 10-Q · filed 2024-11-14 | |
| 2022-09-30 | $25.00K 10-Q · filed 2023-01-06 | |
| 2019-12-31 | $60.00K 10-K · filed 2021-03-04 | |
| 2019-09-30 | $60.00K 10-Q · filed 2020-11-09 | |
| 2017-12-31 | $75.00K 8-K/A · filed 2018-04-06 | |
| 2016-12-31 | $186.00K 8-K/A · filed 2018-04-06 |